Change in inflammatory markers and cognitive status in the oldest-old women from the study of osteoporotic fractures

Journal of the American Geriatrics Society

Volumn 62, Issue 4, 2014, Pages 662-666

  Metti, Andrea L ^a   Yaffe, Kristine ^b,c   Boudreau, Robert M ^a   Ganguli, Mary ^a,d   Lopez, Oscar L ^d   Stone, Katie L ^e   Cauley, Jane A ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

dementia; inflammation; mild cognitive impairment; oldest old

Indexed keywords

CYSTATIN C; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1;

AGED; ARTICLE; CLINICAL TRIAL (TOPIC); COGNITION; COHORT ANALYSIS; DEMENTIA; DISEASE MARKER; FEMALE; FRAGILITY FRACTURE; HUMAN; INFLAMMATION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MILD COGNITIVE IMPAIRMENT; MULTIINFARCT DEMENTIA; RANDOM SAMPLE; RISK ASSESSMENT; SERUM; UNITED STATES; VERY ELDERLY;

DEMENTIA; INFLAMMATION; MILD COGNITIVE IMPAIRMENT; OLDEST OLD;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; COGNITION; COGNITION DISORDERS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; FORECASTING; HUMANS; INFLAMMATION; NEUROPSYCHOLOGICAL TESTS; OSTEOPOROTIC FRACTURES; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84898813502     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.12739     Document Type: Article

References (27)

1. Brumback-Peltz C, Balasubramanian AB, Corrada MM, et al. Diagnosing dementia in the oldest-old. Maturitas 2011; 70: 164-168.
2. Engelhart MJ, Geerlings MI, Meijer J, et al. Inflammatory proteins in plasma and the risk of dementia: The Rotterdam Study. Arch Neurol 2004; 61: 668-672.
3. Schmidt R, Schmidt H, Curb JD, et al. Early inflammation and dementia: A 25-year follow-up of the Honolulu-Asia Aging Study. Ann Neurol 2002; 52: 168-174.
4. Troller JN, Smith E, Baune BT, et al. Systemic inflammation is associated with MCI and its subtypes: The Sydney Memory and Aging Study. Dement Geriatr Cogn Disord 2010; 30: 569-578.
5. Weaver JD, Huang M-H, Albert M, et al. Interleukin-6 and risk of cognitive decline. MacArthur Studies of Successful Aging. Neurology 2002; 59: 371-378.
6. Yaffe K, Lindquist K, Penninx BW, et al. Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology 2003; 61: 76-80.
7. Jenny NS, French B, Arnold AM, et al. Long-term assessment of inflammation and healthy aging in late life: The Cardiovascular Health Study All Stars. J Gerontol A Biol Sci Med Sci 2012; 67A: 970-976.
8. Kravitz BA, Corrada MM, Kawas CH,. High levels of serum C-reactive protein (CRP) are associated with increased risk of all-cause mortality, but not dementia in the oldest-old: Results from the 90+ Study. J Am Geriatr Soc 2009; 57: 641-646.
9. Kravitz BA, Corrada MM, Kawas CH,. Elevated C-reactive protein levels are associated with prevalent dementia in the oldest old. Alzheimers Dement 2009; 5: 318-323.
10. Schram MT, Euser SM, De Craen AJM, et al. Systemic markers of inflammation and cognitive decline in old age. J Am Geriatr Soc 2007; 55: 708-716.
11. Silverman JM, Beeri MS, Schmeidler J, et al. C-reactive protein and memory function suggest antagonistic pleiotropy in very old nondemented subjects. Age Ageing 2009; 38: 237-241.
12. Aisen PS, Shchafer KA, Grundman M, et al. Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: A randomized controlled trial. JAMA 2003; 289: 2819-2826.
13. Breitner JC, Baker LD, Montine TJ, et al. Extended results of the Alzheimer's Disease Anti-Inflammatory Prevention Trial. Alzheimers Dement 2011; 7: 402-411.
14. Fields C, Drye L, Vaidya V, et al. Celecoxib or naproxen treatment does not benefit depressive symptoms in persons age 70 and older: Findings from a randomized controlled trial. Am J Geriatr Psychiatry 2012; 20: 505-513.
15. Middleton LE, Barnes DE, Lui L-Y, et al. Physical activity over the life course and its association with cognitive performance and impairment in old age. J Am Geriatr Soc 2010; 58: 1322-1326.
16. Zeki Al Hazzouri A, Stone KL, Haan MN, et al. Leptin, mild cognitive impairment, and dementia among elderly women. J Gerontol A Biol Sci Med Sci 2012; 68A: 175-180.
17. Petersen RC,. Mild cognitive impairment as a diagnostic entity. J Intern Med 2004; 256: 183-194.
18. Sheikh JI, Yesavage JA, eds. Clinical Gerontology: A Guide to Assessment and Intervention. Geriatric Depression Scale (GDS): Recent Evidence and Development of a Shorter Version. New York: Hawthorne Press, 1986.
19. Kamboh MI, Ferreli RE, Kottke B,. Genetic studies of human apolipoproteins, V: A novel rapid procedure to screen apolipoprotein E polymorphism. J Lipid Res 1988; 29: 1535-1543.
20. Pahor M, Chrischilles EA, Guralink JM, et al. Drug data coding and analysis in epidemiologic studies. Eur J Epidemiol 1994; 10: 405-411.
21. ADAPT Research Group. Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial. Neurology 2007; 68: 1800-1808.
22. Hampel H, Schoen D, Schwarz MJ, et al. Interleukin-6 is not altered in cerebrospinal fluid of first-degree relatives and patients with Alzheimer's disease. Neurosci Lett 1997; 228: 143-146.
23. Angelis P, Scharf S, Mander A, et al. Serum interleukin-6 and interleukin-6 soluble receptor in Alzheimer's disease. Neurosci Lett 1998; 244: 106-108.
24. Marz P, Heese K, Hock C, et al. Interleukin-6 (IL-6) and soluble forms of IL-6 receptors are not altered in cerebrospinal fluid of Alzheimer's disease patients. Neurosci Lett 1997; 239: 29-32.
25. Alley DE, Crimmins E, Brandeen-Roche K, et al. Three-year change in inflammatory markers in elderly people and mortality: The Invecchiare in Chianti Study. J Am Geriatr Soc 2007; 55: 1801-1807.
26. Griffin P, Michel JJ, Huysman K, et al. Integration of immunity with physical and cognitive function in definitions of successful aging. Aging Dis 2012; 3: 34-50.
27. Burton MD, Rytych JL, Freund GG, et al. Central inhibition of interleukin-6 trans-signaling during peripheral infection reduced neuroinflammation and sickness in aged mice. Brain Behav Immun 2013; 30: 66-72.